Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Underhill

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|September 13, 2018
Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthoodZ Liu, J Martin, L Orme, et al.
Internal Medicine Journal|January 29, 2011
Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering CommitteeS Lingaratnam, M A Slavin, B Koczwara, et al.
Internal Medicine Journal|January 29, 2011
An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009S Lingaratnam, M A Slavin, L Mileshkin, et al.
Internal Medicine Journal|August 2, 2014
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyB O'Carrigan, M Fournier, I N Olver, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2015
Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerPenelope E Schofield, M R Stockler, D Zannino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade gliomaK Clarke, R L Basser, C Underhill, et al.
Internal Medicine Journal|August 25, 2016
Guidelines for timely initiation of chemotherapy: a proposed framework for access to medical oncology and haematology cancer clinics and chemotherapy servicesM Alexander, R Beattie-Manning, R Blum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancerA Webb, D Cunningham, J H Scarffe, et al.
British Journal of Cancer|December 3, 2011
The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancerD Goldstein, N Spry, M M Cummins, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 14, 2025
Impacts of a Clinical Quality Registry on Lung Cancer Quality Measures: A Retrospective Observational Study of the Victorian Lung Cancer RegistryR G Stirling, U Samankula, M Lloyd, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|September 13, 2018
Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthoodZ Liu, J Martin, L Orme, et al.
Internal Medicine Journal|January 29, 2011
Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering CommitteeS Lingaratnam, M A Slavin, B Koczwara, et al.
Internal Medicine Journal|January 29, 2011
An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009S Lingaratnam, M A Slavin, L Mileshkin, et al.
Internal Medicine Journal|August 2, 2014
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyB O'Carrigan, M Fournier, I N Olver, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2015
Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerPenelope E Schofield, M R Stockler, D Zannino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade gliomaK Clarke, R L Basser, C Underhill, et al.
Internal Medicine Journal|August 25, 2016
Guidelines for timely initiation of chemotherapy: a proposed framework for access to medical oncology and haematology cancer clinics and chemotherapy servicesM Alexander, R Beattie-Manning, R Blum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancerA Webb, D Cunningham, J H Scarffe, et al.
British Journal of Cancer|December 3, 2011
The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancerD Goldstein, N Spry, M M Cummins, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 14, 2025
Impacts of a Clinical Quality Registry on Lung Cancer Quality Measures: A Retrospective Observational Study of the Victorian Lung Cancer RegistryR G Stirling, U Samankula, M Lloyd, et al.
Pageof 4